Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study

Farhad Ravandi, Rita Assi, Naval Daver, Christopher B. Benton, Tapan M. Kadia, Philip A. Thompson, Gautam Borthakur, Yesid Alvarado, Elias Jabbour, Marina Konopleva,

The Lancet Haematology · 2019 · 137 citations · 27 references

DOIFull text

Open access

Concepts

References

27